Development and Characterization of a Semi-Solid Dosage Form of Meglumine Antimoniate for Topical Treatment of Cutaneous Leishmaniasis

Cutaneous leishmaniasis (CL) is treated with painful intralesional injections of meglumine antimoniate (MA). With the aim of developing an alternative topical treatment for CL, a gel-based formulation with 30% MA was prepared and its physicochemical properties, stability and rheological behavior wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Berenguer, Diana, Sosa, Lilian, Alcover, Magdalena, Sessa, Marcella, Halbaut, Lyda, Guillén, Carme, Fisa, Roser, Calpena-Campmany, Ana Cristina, Riera, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920791/
https://www.ncbi.nlm.nih.gov/pubmed/31731660
http://dx.doi.org/10.3390/pharmaceutics11110613

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920791/
https://www.ncbi.nlm.nih.gov/pubmed/31731660
http://dx.doi.org/10.3390/pharmaceutics11110613

Ejemplares similares